Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal hormone use and lens opacities.

June M Weintraub1, Allen Taylor, Paul Jacques

  • 1Department of Epidemiology, Harvard School of Public Health, Boston, MA. june_weintraub@dph.sf.ca.us

Ophthalmic Epidemiology
|June 5, 2002
PubMed
Summary

Postmenopausal hormone use did not show an overall link to lens opacities. However, current estrogen-only users had a reduced risk of nuclear cataracts, suggesting a potential protective effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial Contusion Due to Ballistic Impact Force.

JACC. Case reports·2025
Same author

Dietary prevention of antibiotic-induced dysbiosis and mortality upon aging in mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2024
Same author

Glycative stress as a cause of macular degeneration.

Progress in retinal and eye research·2024
Same author

Selective transcriptomic dysregulation of metabolic pathways in liver and retina by short- and long-term dietary hyperglycemia.

iScience·2024
Same author

The E3 ligase SMURF1 stabilizes p27 via UbcH7 catalyzed K29-linked ubiquitin chains to promote cell migration SMURF1-UbcH7 K29 ubiquitination of p27 and cell migration.

The Journal of biological chemistry·2024
Same author

Unbalanced redox status network as an early pathological event in congenital cataracts.

Redox biology·2023

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Gerontology

Background:

  • Women experience higher rates of age-related cataract than men.
  • Hormonal differences between genders are hypothesized to contribute to this disparity.
  • Postmenopausal hormone therapy is a common intervention with potential systemic effects.

Purpose of the Study:

  • To investigate the association between postmenopausal hormone use and the development of lens opacities.
  • To determine if specific types of hormone therapy influence cataract risk.
  • To explore gender-related hormonal influences on age-related eye conditions.

Main Methods:

  • A population of 480 postmenopausal women from the Nurses' Health Study was analyzed.
  • Prospective data on hormone exposure and standardized eye examinations were collected.

Related Experiment Videos

  • Lens opacities were quantified using the Lens Opacity Classification System III (LOCS III).

    • Main Results:

    • No significant overall association was found between current hormone use and any type of lens opacity.
    • Current hormone users showed a trend towards lower risk for cortical opacities.
    • Current use of estrogen-only preparations was linked to a 49% reduced risk of nuclear opacities.

    Conclusions:

    • The study did not find a significant overall protective effect of postmenopausal hormone use on lens opacities.
    • A potential protective effect against nuclear opacities was observed in current estrogen-only users.
    • Further research is warranted to clarify the role of specific hormone therapies in cataract prevention.